Karyopharm Therapeutics Inc. Common Stock (KPTI)

Typically moves ±10.17% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-04 ESTIMATED
search

Karyopharm Therapeutics Inc. Common Stock (KPTI) has reported earnings 21 times since Aug 05, 2021. The stock moves an average of ±10.17% the day after reporting, closing higher 38.1% of the time. Its largest post-earnings gain was +36.79% (Nov 03, 2021) and its largest decline was -24.27% (Aug 05, 2021). The next earnings report is predicted for 2026-11-04 (estimated).

Earnings reactions

How KPTI moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

21

Avg Abs. Movement

±10.17%

Positive %

38.1%

Negative %

61.9%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 13, 2026 ☀ PRE -1.97% open_in_new
May 14, 2026 ☀ PRE +0.79% open_in_new
Feb 12, 2026 ☀ PRE +22.01% open_in_new
Nov 03, 2025 ☀ PRE +3.89% open_in_new
event

Earnings Count

21

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.17%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 17 →
17
Funds holding
$45244237
Total value held
Buying
17 added · 0 reduced
Goldman Sachs Group Inc
$13918908 +50.35%
Blackrock, Inc.
$13861666 +479.34%
Ubs Group Ag
$3454135 NEW BUY
State Street Corp
$3184932 +303.74%
Jpmorgan Chase & Co
$2157273 +45315.92%

Frequently asked about KPTI earnings

When does Karyopharm Therapeutics Inc. Common Stock report earnings next? expand_more

Karyopharm Therapeutics Inc. Common Stock (KPTI)'s next earnings date is estimated for 2026-11-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does KPTI stock move after earnings? expand_more

Over 21 reports, KPTI has moved an average of ±10.17% the session after earnings, closing higher 38.1% of the time.

What was KPTI's biggest post-earnings move? expand_more

KPTI's largest post-earnings gain on record was +36.79% on Nov 03, 2021, and its largest decline was -24.27% on Aug 05, 2021.

Where can I find Karyopharm Therapeutics Inc. Common Stock's SEC filings? expand_more

All of Karyopharm Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.